Location: Boston, MA
CIK: 0001703031 · Show all filings
Period: Q4 2020 (← Previous) (Next →)
Filing Date: Feb 16, 2021
Total Value: $1.593B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | SPRINGWORKS THERAPEUTICS INC | 7,281,307 | $528M | 33.2% | $21.68 | — | COM | 85205L107 |
| AVIR | ATEA PHARMACEUTICALS, INC. | 5,615,659 | $235M | 14.7% | $32.23 | 0.0% | COM | 04683R106 |
| ARQT | ARCUTIS BIOTHERAPEUTICS, INC. | 3,979,292 | $112M | 7.0% | $26.87 | -8.8% | COM | 03969K108 |
| — | MERSANA THERAPEUTICS | 3,445,667 | $91.69M | 5.8% | $23.40 | — | COM | 59045L106 |
| ANNX | ANNEXON INC | 3,241,628 | $81.14M | 5.1% | $23.46 | +9.7% | COM | 03589W102 |
| — | DICERNA PHARMACEUTICALS INC | 3,080,237 | $67.86M | 4.3% | $9.03 | — | COM | 253031108 |
| — | SYROS PHARMACEUTICALS, INC. | 5,785,036 | $62.77M | 3.9% | $10.85 | — | COM | 87184Q107 |
| CCCC | C4 THERAPEUTICS, INC. | 1,642,209 | $54.41M | 3.4% | $29.00 | 0.0% | COM STK | 12529R107 |
| — | SOLID BIOSCIENCES INC | 7,060,353 | $53.52M | 3.4% | $8.29 | — | COM | 83422E105 |
| — | DYNAVAX TECHNOLOGIES CORP | 10,895,773 | $48.49M | 3.0% | $4.45 | — | COM | 268158901 |
| NRIX | NURIX THERAPEUTICS, INC. | 1,284,314 | $42.23M | 2.7% | $25.20 | +31.5% | COM | 67080M103 |
| — | CONSTELLATION PHARMACEUTICALS, INC. | 1,400,000 | $40.32M | 2.5% | $47.11 | — | COM | 210373106 |
| — | APTINYX INC | 8,891,758 | $30.77M | 1.9% | $8.16 | — | COM | 03836N103 |
| KYMR | KYMERA THERAPEUTICS INC. | 479,605 | $29.73M | 1.9% | $30.53 | +59.8% | COM | 501575104 |
| — | AEGLEA BIO THERAPEUTICS | 2,700,000 | $21.25M | 1.3% | $9.25 | — | COM | 00773J103 |
| — | MARINUS PHARMACEUTICALS INC | 1,431,058 | $17.46M | 1.1% | $6.30 | — | COM | 56854Q101 |
| CRNX | CRINETICS PHAMACEUTICALS | 1,071,428 | $15.12M | 0.9% | $17.05 | -18.3% | COM | 22663K107 |
| — | THERAPEUTICS ACQUISITION COR | 1,000,000 | $13.92M | 0.9% | $14.38 | — | COM CL A | 88339T103 |
| — | ARYA SCIENCES ACQUISITION CORP III | 1,000,000 | $10.85M | 0.7% | $10.81 | — | COM CL A | G3166W106 |
| — | X4 PHARMACEUTICALS INC | 1,648,485 | $10.6M | 0.7% | $10.70 | — | COM | 98420X103 |
| SVRA | SAVARA INC | 5,128,593 | $5.898M | 0.4% | $1.20 | +0.1% | COM | 805111101 |
| — | BCTG ACQUISITION CORP | 500,000 | $5.72M | 0.4% | $10.36 | — | COM | 05492W103 |
| — | BCLS ACQUISITION CORP | 487,500 | $5.431M | 0.3% | $11.14 | — | COM CL A | G0904B105 |
| — | FRAZIER LIFESCIENCES ACQUISITION CORP | 300,000 | $3.114M | 0.2% | $10.38 | — | UNIT 12/09/2025 | G3710A121 |
| — | JIYA ACQUISITION CORP | 300,000 | $3.09M | 0.2% | $10.30 | — | COM CL A | 47760M102 |
| MLTX | HELIX ACQUISITION CORP | 250,000 | $2.843M | 0.2% | $11.37 | — | COM CL A | G4444C102 |